Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

UTair passenger traffic on airplanes in January-October increased by 9.8%

11/21/23 UTAR

Magnit will expand the network of MCosmetic stores in Uzbekistan

11/21/23 MGNT

Astra may hold an SPO in the next two years

11/21/23 ASTR

Polymetal launched equipment from Turkey at Prognoz field

11/21/23 POLY

UWC completed the collection of applications for participation in the additional share issue

11/20/23 UWGN

Sanctions against Arctic LNG-2 may deprive Novatek of 4% of market

11/20/23 NVTK

Xiaomi has reported for 9 months of 2023

11/20/23 1810

VEON reported for 9 months of 2023

11/20/23 VEON

Board of Directors of Pharmsintez proposed an additional share issue

11/20/23 LIFE

Magnit will expands the geography of sales of ready-to-eat food in stores at home

11/20/23 MGNT